GWW vs GYRE · P/E 27, rev $9.76B vs rev $53.5M
WW Grainger Inc (GWW) versus Gyre Therapeutics Inc. (GYRE) — a side-by-side from cached financials, not a winner call.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
GWW currently screens at market cap $50.34B and trailing P/E 26.9. GYRE currently screens at market cap $589.9M.
Not investment advice. Open the GWW and GYRE stock pages for the full models.
Not investment advice.